IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo
- PMID: 26783184
- DOI: 10.1136/gutjnl-2015-310374
IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo
Abstract
Objective: Interleukin (IL)-36R signalling plays a proinflammatory role in different organs including the skin, but the expression of IL-36R ligands and their molecular function in intestinal inflammation are largely unknown.
Design: We studied the characteristics of IL-36R ligand expression in IBDs and experimental colitis. The functional role of IL-36R signalling in the intestine was addressed in experimental colitis and wound healing models in vivo by using mice with defective IL-36R signalling (IL-36R-/-) or Myd88, neutralising anti-IL-36R antibodies, recombinant IL-36R ligands and RNA-seq genome expression analysis.
Results: Expression of IL-36α and IL-36γ was significantly elevated in active human IBD and experimental colitis. While IL-36γ was predominantly detected in nuclei of the intestinal epithelium, IL-36α was mainly found in the cytoplasm of CD14+ inflammatory macrophages. Functional studies showed that defective IL-36R signalling causes high susceptibility to acute dextran sodium sulfate colitis and impairs wound healing. Mechanistically, IL-36R ligands released upon mucosal damage activated IL-36R+ colonic fibroblasts via Myd88 thereby inducing expression of chemokines, granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-6. Moreover, they induced proliferation of intestinal epithelial cells (IECs) and expression of the antimicrobial protein lipocalin 2. Finally, treatment of experimental intestinal wounds with IL-36R ligands significantly accelerated mucosal healing in vivo.
Conclusions: IL-36R signalling is activated upon intestinal damage, stimulates IECs and fibroblasts and drives mucosal healing. Modulation of the IL-36R pathway emerges as a potential therapeutic strategy for induction of mucosal healing in IBD.
Keywords: INFLAMMATORY BOWEL DISEASE; INTERLEUKINS; MUCOSAL INJURY.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Similar articles
-
Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.Gastroenterology. 2017 Jul;153(1):123-138.e8. doi: 10.1053/j.gastro.2017.03.015. Epub 2017 Mar 23. Gastroenterology. 2017. PMID: 28342759
-
Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage.J Immunol. 2016 Jan 1;196(1):34-8. doi: 10.4049/jimmunol.1501312. Epub 2015 Nov 20. J Immunol. 2016. PMID: 26590314 Free PMC article.
-
Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.Gastroenterology. 2019 Mar;156(4):1082-1097.e11. doi: 10.1053/j.gastro.2018.11.029. Epub 2018 Nov 16. Gastroenterology. 2019. PMID: 30452921
-
IL-36 cytokines and gut immunity.Immunology. 2021 Jun;163(2):145-154. doi: 10.1111/imm.13310. Epub 2021 Feb 24. Immunology. 2021. PMID: 33501638 Free PMC article. Review.
-
Regulation and function of interleukin-36 cytokines.Immunol Rev. 2018 Jan;281(1):169-178. doi: 10.1111/imr.12610. Immunol Rev. 2018. PMID: 29247994 Review.
Cited by
-
Borrelia burgdorferi initiates early transcriptional re-programming in macrophages that supports long-term suppression of inflammation.PLoS Pathog. 2023 Dec 29;19(12):e1011886. doi: 10.1371/journal.ppat.1011886. eCollection 2023 Dec. PLoS Pathog. 2023. PMID: 38157387 Free PMC article.
-
The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis.Int J Mol Sci. 2019 Jul 5;20(13):3318. doi: 10.3390/ijms20133318. Int J Mol Sci. 2019. PMID: 31284527 Free PMC article. Review.
-
Regulation of the Peptidoglycan Amidase PGLYRP2 in Epithelial Cells by Interleukin-36γ.Infect Immun. 2018 Aug 22;86(9):e00384-18. doi: 10.1128/IAI.00384-18. Print 2018 Sep. Infect Immun. 2018. PMID: 29914927 Free PMC article.
-
IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.Front Immunol. 2018 Feb 26;9:200. doi: 10.3389/fimmu.2018.00200. eCollection 2018. Front Immunol. 2018. PMID: 29535706 Free PMC article.
-
Floxed Il1rl2 Locus with mCherry Reporter Element Reveals Distinct Expression Patterns of the IL-36 Receptor in Barrier Tissues.Cells. 2024 May 6;13(9):787. doi: 10.3390/cells13090787. Cells. 2024. PMID: 38727323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials